Overview

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386

Status:
Completed
Trial end date:
2021-03-30
Target enrollment:
Participant gender:
Summary
A Clinical Trial to evaluate the Pharmacokinetics and Tolerability of CKD-386
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical